These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33980826)

  • 1. Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis.
    Dika E; Broseghini E; Porcellini E; Lambertini M; Riefolo M; Durante G; Loher P; Roncarati R; Bassi C; Misciali C; Negrini M; Rigoutsos I; Londin E; Patrizi A; Ferracin M
    Cell Death Dis; 2021 May; 12(5):473. PubMed ID: 33980826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line].
    Wang D; Li YJ; Ding N; Wang JY; Yang Q; Yang YR; Li YM; Fang XD; Zhao H
    Yi Chuan; 2015 Jul; 37(7):673-82. PubMed ID: 26351167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
    Murria Estal R; de Unamuno Bustos B; Pérez Simó G; Simarro Farinos J; Torres Navarro I; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Melanoma Res; 2021 Feb; 31(1):18-26. PubMed ID: 33234848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-depth characterization of microRNA transcriptome in melanoma.
    Kozubek J; Ma Z; Fleming E; Duggan T; Wu R; Shin DG; Dadras SS
    PLoS One; 2013; 8(9):e72699. PubMed ID: 24023765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel MicroRNA Biomarkers,
    Xu Y; Wang L; Jiang L; Zhang X
    J Comput Biol; 2020 May; 27(5):815-824. PubMed ID: 31526187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary study of microRNA expression in different types of primary melanoma.
    Gencia I; Baderca F; Avram S; Gogulescu A; Marcu A; Seclaman E; Marian C; Solovan C
    Bosn J Basic Med Sci; 2020 May; 20(2):197-208. PubMed ID: 31479413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
    Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M
    J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.
    Antonova E; Hambikova A; Shcherbakov D; Sukhov V; Vysochanskaya S; Fadeeva I; Gorshenin D; Sidorova E; Kashutina M; Zhdanova A; Mitrokhin O; Avvakumova N; Zhernov Y
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected isomiR expression profiles via arm switching?
    Guo L; Zhang H; Zhao Y; Yang S; Chen F
    Gene; 2014 Jan; 533(1):149-55. PubMed ID: 24120620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.
    Babapoor S; Wu R; Kozubek J; Auidi D; Grant-Kels JM; Dadras SS
    Lab Invest; 2017 Jun; 97(6):636-648. PubMed ID: 28218741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
    DiVincenzo MJ; Angell CD; Suarez-Kelly LP; Ren C; Barricklow Z; Moufawad M; Fadda P; Yu L; Backes FJ; Ring K; Mills A; Slingluff C; Chung C; Gru AA; Carson WE
    PLoS One; 2023; 18(6):e0285804. PubMed ID: 37384650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
    Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV
    Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
    Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
    Front Oncol; 2020; 10():756. PubMed ID: 32509578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.
    DiVincenzo MJ; Schwarz E; Ren C; Barricklow Z; Moufawad M; Yu L; Fadda P; Angell C; Sun S; Howard JH; Chung C; Slingluff C; Gru AA; Kendra K; Carson WE
    J Invest Dermatol; 2023 Apr; 143(4):630-638.e3. PubMed ID: 36202232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma.
    Polini B; Carpi S; Doccini S; Citi V; Martelli A; Feola S; Santorelli FM; Cerullo V; Romanini A; Nieri P
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.